Search research articles
Contact Us
Filters
Showing results (31-40 of 89) with videos related to
Page
of 9
Sort By:
American Journal of Clinical Oncology
|
October 1, 1986
5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lung
F A Shepherd, W K Evans, R Burkes, et al.
Journal of the National Cancer Institute
|
December 9, 1997
P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapy
H S Chan, T M Grogan, G Haddad, et al.
Seminars in Oncology
|
September 1, 1986
First-line therapy with VP-16 and cisplatin for small-cell lung cancer
W K Evans, F A Shepherd, R Feld, et al.
Cancer Treatment Reports
|
February 1, 1985
Phase II evaluation of bisantrene in patients with advanced non-small cell lung carcinoma
R Feld, W K Evans, F A Shepherd, et al.
Carcinogenesis
|
June 29, 1999
Oxazepam is mutagenic in vivo in Big Blue transgenic mice
B S Shane, J G deBoer, B W Glickman, et al.
American Journal of Hospital Pharmacy
|
February 1, 1986
Limitations of urinary mutagen assays for monitoring occupational exposure to antineoplastic drugs
P G Tuffnell, M T Gannon, A Dong, et al.
BJU International
|
April 18, 2003
Are serial bone scans useful for the follow-up of clinically localized, low to intermediate grade prostate cancer managed with watchful observation alone?
B K Yap, R Choo, G Deboer, et al.
Anesthesiology
|
June 1, 1995
Intraoperative hyperkalemia as a triggering mechanism or presenting sign of malignant hyperthermia in two patients with chronic renal failure
J Sprung, G DeBoer, G Zanettin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1985
VP-16 and cisplatin as first-line therapy for small-cell lung cancer
W K Evans, F A Shepherd, R Feld, et al.
Annals of Internal Medicine
|
October 1, 1986
Is bone marrow examination in small-cell lung cancer really necessary?
B Campling, I Quirt, G DeBoer, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 89) with videos related to
Sort By:
Page
of 9
American Journal of Clinical Oncology
|
October 1, 1986
5-Fluorouracil, adriamycin, and mitomycin-C (FAM) in the treatment of inoperable adenocarcinoma of the lung
F A Shepherd, W K Evans, R Burkes, et al.
Journal of the National Cancer Institute
|
December 9, 1997
P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapy
H S Chan, T M Grogan, G Haddad, et al.
Seminars in Oncology
|
September 1, 1986
First-line therapy with VP-16 and cisplatin for small-cell lung cancer
W K Evans, F A Shepherd, R Feld, et al.
Cancer Treatment Reports
|
February 1, 1985
Phase II evaluation of bisantrene in patients with advanced non-small cell lung carcinoma
R Feld, W K Evans, F A Shepherd, et al.
Carcinogenesis
|
June 29, 1999
Oxazepam is mutagenic in vivo in Big Blue transgenic mice
B S Shane, J G deBoer, B W Glickman, et al.
American Journal of Hospital Pharmacy
|
February 1, 1986
Limitations of urinary mutagen assays for monitoring occupational exposure to antineoplastic drugs
P G Tuffnell, M T Gannon, A Dong, et al.
BJU International
|
April 18, 2003
Are serial bone scans useful for the follow-up of clinically localized, low to intermediate grade prostate cancer managed with watchful observation alone?
B K Yap, R Choo, G Deboer, et al.
Anesthesiology
|
June 1, 1995
Intraoperative hyperkalemia as a triggering mechanism or presenting sign of malignant hyperthermia in two patients with chronic renal failure
J Sprung, G DeBoer, G Zanettin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1985
VP-16 and cisplatin as first-line therapy for small-cell lung cancer
W K Evans, F A Shepherd, R Feld, et al.
Annals of Internal Medicine
|
October 1, 1986
Is bone marrow examination in small-cell lung cancer really necessary?
B Campling, I Quirt, G DeBoer, et al.
Page
of 9